Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Halma plc ( (GB:HLMA) ).
Halma has acquired California‑based Surgistar, Inc., a specialist designer and manufacturer of ophthalmic surgical instruments such as blades, cannulas and trephines, for $90m in cash on a debt‑free, cash‑free basis funded from existing facilities. The deal is a bolt‑on acquisition for Halma’s Healthcare sector business MicroSurgical Technology, enhancing its ophthalmic product range and manufacturing capabilities while leveraging MST’s global distribution channels, underscoring Halma’s strategy of using targeted acquisitions to deepen its presence in high‑growth medical device niches.
Surgistar’s highly automated production processes are expected to support consistent product quality and long‑term growth for MST’s portfolio. By strengthening its ophthalmic offering, Halma further consolidates its position in specialised healthcare technologies, potentially improving its competitive standing in the global eye‑surgery market and adding scale to its healthcare operations without straining its balance sheet.
The most recent analyst rating on (GB:HLMA) stock is a Hold with a £4150.00 price target. To see the full list of analyst forecasts on Halma plc stock, see the GB:HLMA Stock Forecast page.
Spark’s Take on HLMA Stock
According to Spark, TipRanks’ AI Analyst, HLMA is a Outperform.
Halma plc’s overall stock score reflects its strong financial performance and positive earnings call sentiment, supported by strategic corporate actions. However, the high valuation and modest dividend yield slightly temper the overall attractiveness.
To see Spark’s full report on HLMA stock, click here.
More about Halma plc
Halma plc is a global group of life‑saving technology companies operating across safety, environmental and healthcare markets. The FTSE 100‑listed group employs over 9,000 people in more than 20 countries, focusing on products and solutions that protect people and assets, address climate and pollution challenges, and meet growing demand for better healthcare worldwide.
Average Trading Volume: 1,232,881
Technical Sentiment Signal: Buy
Current Market Cap: £15.72B
For an in-depth examination of HLMA stock, go to TipRanks’ Overview page.